Petros Pharma Introduces AI As ACNU Option In Research For OTC Switch Of Stendra ED Drug

Petros is first to introduce an OTC switch labeling tool which could be the next obvious step hiding in plain sight – AI, which wasn’t noted in FDA’s ACNU proposal and hasn’t previously been linked to a switch.